Sequential changes in motor speech across a levodopa cycle in advanced Parkinson's disease

References

• Adelman, J. U., Hoel, R. L., Lassman, M. E. (1970). The effect of L-DOPA treatment on speech of patients with Parkinson's disease. Neurology, 20, 410–411.
   Web of Science ®Google Scholar
• Braak, H., Del Tredici, K., Rub, U., de Vos, R. A., Jansen Steur, E. N., Braak, E. (2003). Staging of brain pathology related to sporadic Parkinson's disease. Neurobiological Aging, 24, 197–211.
   PubMed Web of Science ®Google Scholar
• Cahill, L. M., Murdoch, B. E., Theodoros, D. G., Triggs, E. J., Charles, B. G., Yao, A. A. (1998). Effect of oral levodopa treatment on articulatory function in Parkinson's disease: Preliminary results. Motor Control, 2, 161–172.
   PubMedGoogle Scholar
• Critchley, E. M. (1981). Speech disorders of Parkinsonism: A review. Journal of Neurology, Neurosurgery and Psychiatry, 44, 751–758.
   PubMed Web of Science ®Google Scholar
• De Letter, M., Santens, P., Van Borsel, J. (2003). The effects of levodopa on tongue strength and endurance in patients with Parkinson's disease. Acta Neurologica Belgica, 103, 35–38.
   PubMed Web of Science ®Google Scholar
• De Letter, M., Santens, P., Van Borsel, J. (2005). The effects of levodopa on word intelligibility in Parkinson's disease. Journal of Communication Disorders, 38, 187–196.
   PubMed Web of Science ®Google Scholar
• De Letter, M., Santens, P., De Bodt, M., Boon, P., Van Borsel, J. (2006). Levodopa-induced alterations in speech rate in advanced Parkinson's disease. Acta Neurologica Belgica, 106, 19–26.
   PubMed Web of Science ®Google Scholar
• De Letter, M., Santens, P., De Bodt, M., Van Maele, G., Van Borsel, J., Boon, P. (2007a). The effect of levodopa on respiration and word intelligibility in people with advanced Parkinson's disease. Clinical Neurology and Neurosurgery, 109, 495–500.
   PubMed Web of Science ®Google Scholar
• De Letter, M., Santens, P., Estercam, I., Van Maele, G., De Bodt, M., Boon, P., et al (2007b). Levodopa-induced modifications of prosody and comprehensibility in advanced Parkinson's disease as perceived by professional listeners. Clinical Linguistics and Phonetics, 21, 783–791.
   PubMed Web of Science ®Google Scholar
• Defer, G. L., Widner, H., Marie, R. M., Remy, P., Levivier, M. (1999). Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD). Movement Disorders, 14, 572–584.
   PubMed Web of Science ®Google Scholar
• Dykstra, A. D., Hakel, M. E., Adams, S. G. (2007). Application of the ICF in reduced speech intelligibility in dysarthria. Seminars in Speech and Language, 28, 301–311.
   PubMedGoogle Scholar
• Enderby, P. (1980). Frenchay Dysarthria Assessment. International Journal of Language and Communication Disorders, 15, 165–173.
   Google Scholar
• Fahn, S., Elton, R. L., Members of the UPDRS Development Committee (1987). Unified Parkinson's disease rating scale. In S. Fahn, C. D. Marsden, D. Calne, M. Goldstein (Eds.), Recent developments in Parkinson's disease 2 ( pp. 153–163). Florham Park, NJ: Macmillan Healthcare Information.
   Google Scholar
• Folstein, M. F., Folstein, S. E., McHugh, P. R. (1975). Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189–198.
   PubMed Web of Science ®Google Scholar
• Gardner, W. N., Langdon, N., Parkes, J. D. (1987). Breathing in Parkinson's disease. Advances in Neurology, 45, 271–274.
   Google Scholar
• Gentil, M., Tournier, C. L., Pollak, P., Benabid, A. L. (1999). Effect of bilateral subthalamic nucleus stimulation and dopatherapy on oral control in Parkinson's disease. European Neurology, 42, 136–140.
   PubMed Web of Science ®Google Scholar
• Goberman, A., McMillan, J. (2005). Relative speech timing in Parkinson's disease. Continuing Issues in Communication Science and Disorders, 2005, 22–29.
   Google Scholar
• Goberman, A. M., Coelho, C. (2002). Acoustic analysis of Parkinsonian speech II: L-Dopa related fluctuations and methodological issues. NeuroRehabilitation, 17, 247–254.
   PubMed Web of Science ®Google Scholar
• Goberman, A. M., Coelho, C., Robb, M. (2002). Phonatory characteristics of Parkinsonian speech before and after morning medication: The ON and OFF states. Journal of Communication Disorders, 35, 217–239.
   PubMed Web of Science ®Google Scholar
• Hage, R., Jurgens, U. (2006). On the role of the pontine brainstem in vocal pattern generation: A telemetric single-unit recording study in the squirrel monkey. The Journal of Neuroscience, 26, 7105–7115.
   Google Scholar
• Hage, S. R., Jurgens, U., Ehret, G. (2006). Audio-vocal interaction in the pontine brainstem during self-initiated vocalization in the squirrel monkey. European Journal of Neuroscience, 23, 3297–3308.
   Web of Science ®Google Scholar
• Harel, B., Cannizzaro, M., Snyder, P. J. (2004). Variability in fundamental frequency during speech in prodromal and incipient Parkinson's disease: A longitudinal case study. Brain and Cognition, 56, 24–29.
   PubMed Web of Science ®Google Scholar
• Ho, A. K., Bradshaw, J. L., Iansek, R. (2008). For better or worse: The effect of levodopa on speech in Parkinson's disease. Movement Disorders, 15, 574–580.
   Google Scholar
• Hoehn, M. M., Yahr, M. D. (1998). Parkinsonism: Onset, progression and mortality. Neurology, 50, 318–333.
   PubMed Web of Science ®Google Scholar
• Kleinow, J., Smith, A., Ramig, L. O. (2001). Speech motor stability in IPD: Effects of rate and loudness manipulations. Journal of Speech, Language, and Hearing Research, 44, 1041–1051.
   PubMed Web of Science ®Google Scholar
• Kompoliti, K., Wang, Q. E., Goetz, C. G., Leurgans, S., Raman, R. (2000). Effects of central dopaminergic stimulation by apomorphine on speech in Parkinson's disease. Neurology, 25, 458–462.
   Google Scholar
• Limousin, P., Krack, P., Pollak, P., Benazzouz, A., Ardouin, C., Hoffmann, D., et al (1998). Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. New England Journal of Medicine, 15, 1105–1111.
   Google Scholar
• Louis, E. D., Winfield, L., Fahn, S., Ford, B. (2001). Speech dysfluency exacerbated by levodopa in Parkinson's disease. Movement Disorders, 16, 562–565.
   Google Scholar
• MacKay-Lyons, K. (1999). Variability in spatiotemporal gait characteristics over the course of the L-dopa cycle in people with advanced Parkinson disease. Physical Therapy, 78, 1083–1094.
   Google Scholar
• Metter, E. J., Hanson, W. R. (1986). Clinical and acoustical variability in hypokinetic dysarthria. Journal of Communication Disorders, 19, 347–366.
   PubMed Web of Science ®Google Scholar
• Murdoch, B. E., Chenery, H. J., Bowler, S., Ingram, J. C. (1989). Respiratory function in Parkinson's subjects exhibiting a perceptible speech deficit: A kinematic and spirometric analysis. Journal of Speech and Hearing Disorders, 54, 610–626.
   PubMedGoogle Scholar
• Nakano, K. K., Zubick, H., Tyler, H. R. (1973). Speech defects of Parkinsonian patients: Effects of levodopa therapy on speech intelligibility. Neurology, 23, 865–870.
   PubMed Web of Science ®Google Scholar
• Olanow, C. W., Gauger, L. L., Cedarbaum, J. M. (1991). Temporal relationships between plasma and cerebrospinal fluid pharmacokinetics of levodopa and clinical effect in Parkinson's disease. Annals of Neurology, 29, 556–559.
   PubMed Web of Science ®Google Scholar
• Poluha, P. C., Teulings, H. L., Brookshire, R. H. (1998). Handwriting and speech changes across the levodopa cycle in Parkinson's disease. Acta Psychologica, 100, 71–84.
   PubMed Web of Science ®Google Scholar
• Rice, J. E., Antic, R., Thompson, P. D. (2002). Disordered respiration as a levodopa-induced dyskinesia in Parkinson's disease. Movement Disorders, 17, 524–527.
   PubMed Web of Science ®Google Scholar
• Sanabria, J., Ruiz, P. G., Gutierrez, R., Marquez, F., Escobar, P., Gentil, M., et al (2001). The effect of levodopa on vocal function in Parkinson's disease. Clinical Neuropharmacology, 24, 99–102.
   PubMed Web of Science ®Google Scholar
• Santens, P., De Letter, M., Van Borsel, J., De Reuck, J., Caemaert, J. (2003). Lateralized effects of subthalamic nucleus stimulation on different aspects of speech in Parkinson's disease. Brain and Language, 87, 253–258.
   PubMed Web of Science ®Google Scholar
• Schulz, G. M., Varga, M., Jeffires, K., Ludlow, C. L., Braun, A. R. (2005). Functional neuroanatomy of human vocalization: An H215O PET study. Cerebral Cortex, 15, 1835–1847.
   PubMed Web of Science ®Google Scholar
• Solomon, N. P., Hixon, T. J. (1993). Speech breathing in Parkinson's disease. Journal of Speech and Hearing Research, 36, 294–310.
   PubMedGoogle Scholar
• Solomon, N. P., Robin, D. A., Luschei, E. S. (2000). Strength, endurance and stability of the tongue and hand in Parkinson disease. Journal of Speech, Language and Hearing Research, 43, 256–267.
   PubMed Web of Science ®Google Scholar
• Steiger, M. J., Thompson, P. D., Marsden, C. D. (1996). Disordered axial movement in Parkinson's disease. Journal of Neurology, Neurosurgery and Psychiatry, 61, 645–648.
   PubMed Web of Science ®Google Scholar
• Vercueil, L., Linard, J., Wuyam, B., Pollak, P., Benchetrit, G. (1999). Breathing pattern in patients with Parkinson's disease. Respiratory Physiology, 118, 163–172.
   PubMedGoogle Scholar
• Wolfe, V. I., Garvin, J. S., Bacon, M., Waldrop, W. (1975). Speech changes in Parkinson's disease during treatment with L-dopa. Journal of Communication Disorders, 8, 271–279.
   PubMed Web of Science ®Google Scholar